The 3.6 million shares have all been sold.....With respect to the 40,000 note that was due on May 23 and the other 40,000 note that is due on June 23: Both notes were issued to the same investor. Although CardioGenics is currently negociating with the investor it appears to me that there are only three outcomes: One-- The investor agrees to accept additional money and extends the time period; Two-- The investor wants the shares now and the Company issues 5-6 million additional shares; Three-- CardioGenics defaults and the investor sues...Obviously the first alternative is the best and IMO, the second alternative is the worst.